Abstract
The pharmacological activity of orally administered lysozyme, for the control of the growth of solid tumor metastases, was examined in mice bearing Lewis lung carcinoma. Groups of at least 10 tumor-bearing mice, fed daily for three consecutive weeks from subcutaneous tumor implantation with lysozyme, prepared from hen egg-white, had a pronounced reduction of the weight of their metastatic tumor to 25–50 per cent of controls within a wide range of doses (25–200mg/kg/day). The antimetastatic effect was not related to the length of the treatment schedule employed; a short course of 7 days, given on days 1–7 after tumor implantation, proved equally active. The inhibition of the formation of lung metastases, in mice treated with lysozyme prior to tumor inoculation, lasts for at least 2 weeks after discontinuation of treatment, indicating that the antimetastatic activity observed is not associated with cytotoxic activity of the lysozyme, and is probably mediated by the elicitation of host responses. The examination of the therapeutic potential of the antimetastatic action of lysozyme supplied throught the usual diet indicates that this treatment synergizes with the antitumor effects of cisplatin, given to mice after surgical removal of the primary tumor, causing a statistically significant prolongation of the survival time of the animals as compared with chemotherapy alone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldwin, R. W., 1982, Manipulation of host resistance in cancer therapy.Springer Seminars in Immunopathology,5, 113–125.
Chedid, L., 1983, Muramyl peptides as possible endogenous immunopharmacological mediators.Microbiology and Immunology,27, 723–732.
Collet, B., Martin, A., Le Garrec, Y., Dubray, G., andToujas, L., 1983, Antitumor activity of cell walls fromBruceila abortus.Journal of the National Cancer Institute,71, 529–534.
Fidler, I. J., Barnes, Z., Fogler, W. E., Kirsh, R., Bugelski, P., andPoste, G., 1982, Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.Cancer Research,42, 496–501.
Gouguel, A. F., Lespinats, G., andNauciel, C., 1982, Peptidoglycans extracted from Gram-positive bacteria: expression of antitumor activity according to peptide structure and route of injection.Journal of the National Cancer Institute,68, 657–663.
Gouguel, A. F., Payelle, B., Lespinats, G., andNauciel, C., 1983., Cytotoxic responses induced by peptidoglycans with or withoutin vivo antitumor activity.Journal of the National Cancer Institute,71, 325–330.
Hrsak, I., Tomasic, J., andOsmak, M., 1983, Immunotherapy of B-16 melanoma with peptidoglycan monomer.European Journal of Cancer and Clinical Oncology,19, 681–686.
Inamura, N., Fujitsu, T., Nakahara, K., Abiko, M., Horii, T., Hashimoto, S., andAoki, H., 1984, Potentiation of tumoricidal properties of murine macrophages byNocardia rubra cell wall skeleton (N-CWS).Journal of Antibiotics,37, 244–252.
James, S. E., andSalsbury, A. J., 1974, Effect of (±)-1, 2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect on the Lewis lung carcinoma.Cancer Research,34, 839–842.
Jollès, P., 1976, A possible physiological function of lysozyme.Biomedicine,25, 275–276.
Jollès, P., andWerner, G. H., 1981, What's new in immunomodulation.Trends in Biochemical Sciences,6, 331–333.
Lemarbre, P., Rinehart, J. J., Kay, N. E., Vesella, R., andJacob, H. S., 1981, Lysozyme enhances monocyte-mediated tumoricidal activity: a potential amplifying mechanism of tumor killing.Blood,58, 994–999.
Namba, Y., Hidaka, Y., Taki, K., andMorimoto, T., 1981, Effects of oral administration of lysozyme or digested cell walls on immunostimulation in guinea pig.Infection and Immunity,31, 580–583.
North, R. J., Dye, K. S., Mills, C. D., andChandler, J. P., 1982, Modulation of antitumor immunity-immunobiologic approaches.Springer Seminars in Immunopathology,5, 193–220.
Osserman, E. F., Klockars, M., Halper, J., andFischel, R. E., 1973, Effects of lysozyme on normal and transformed mammalian cells.Nature,243, 331–335.
Rinehart, J., Jacobs, H., andOsserman, E., 1979, Lysozyme modulation of lymphocyte proliferation.Clinical Research,27, 305A.
Rosenberg, B., 1980, Clinical aspects of platinum anticancer drugs.Metal Ions in Biological Systems, edited by H. Sigel (New York: Marcel Dekker Inc.), Vol. 11, pp. 127–196.
Sacchi, A., Corsi, A., Caputo, M., andZupi, G., 1979,In vitro andin vivo selection of two Lewis lung carcinoma cell lines.Tumori,65, 657–664.
Sava, G., Giraldi, T., Tomasic, J., andHrsak, I., 1983, Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan monomer.Cancer Immunology and Immunotherapy,15, 84–86.
Sava, G., Tomasic, J., andHrsak, I., 1984, Antitumor and antimetastatic activity of the immunoadjuvant peptidoglycan monomer PGM in mice bearing MCa mammary carcinoma.Cancer Immunology and Immunotherapy,18, 49–53.
Siegel, S., 1956, The Mann-Whitney U test.Non parametric Statistics for the Behavioral Sciences (New York: McGraw-Hill), pp. 116–127.
Simpson-Herren, L., Sandford, A. H., andHolmquist, J. P., 1976, Effects of surgery on the cell kinetics of residual tumor.Cancer Treatment Reports,60, 1740–1760.
Snedecor, G. W., andCochran, W. G., 1967,Statistical Methods (Ames, Iowa: Iowa University Press), pp. 258–298.
Sokal, R. R., andRohlf, F. J., 1969, Single classification analysis of variance.Biometry, (San Francisco: W. H. Freeman), pp. 204–252.
Vosika, G. J., 1983, Clinical immunotherapy trials of bacterial components derived from mycobacteria and nocardia.Journal of Biological Response Modifiers,2, 321–342.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sava, G., Perissin, L. & Zorzet, S. Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung carcinoma. Clin Exp Metast 6, 245–253 (1988). https://doi.org/10.1007/BF01782484
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01782484